{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:47:44Z","timestamp":1792396064437,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Telethon Foundation","doi-asserted-by":"publisher","award":["GMR22T1082"],"award-info":[{"award-number":["GMR22T1082"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013927","name":"National MPS Society","doi-asserted-by":"publisher","award":["1719"],"award-info":[{"award-number":["1719"]}],"id":[{"id":"10.13039\/100013927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013927","name":"National MPS Society","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/100013927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ymgme.2025.109224","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:59:39Z","timestamp":1755809979000},"page":"109224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Progressive activation of the astrocyte A1 phenotype underlies microglia-astroglia crosstalk and contributes to neuroinflammation in neuronopathic MPS"],"prefix":"10.1016","volume":"146","author":[{"given":"Andrea","family":"Parente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Borzacchiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Giaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Bamundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"D'Auria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Fraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109224_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fnmol.2020.00037","article-title":"Protein aggregation and dysfunction of autophagy-lysosomal pathway: a vicious cycle in lysosomal storage diseases","volume":"13","author":"Monaco","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109224_bb0010","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1080\/15548627.2021.1961076","article-title":"Protein aggregation and autophagy dysfunction: new lessons from mucopolysaccharidoses","volume":"17","author":"Monaco","year":"2021","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.ymgme.2025.109224_bb0015","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1016\/j.ymthe.2024.09.030","article-title":"Anti-amyloid treatment is broadly effective in neuronopathic mucopolysaccharidoses and synergizes with gene therapy in MPS-IIIA","volume":"32","author":"Giaccio","year":"2024","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109224_bb0020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/jnc.14632","article-title":"The role of innate immunity in mucopolysaccharide diseases","volume":"148","author":"Parker","year":"2019","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109224_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002296","article-title":"Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice","volume":"3","author":"Ausseil","year":"2008","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109224_bb0030","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911185","article-title":"Haematopoietic stem cell gene therapy with IL-1Ra rescues cognitive loss in mucopolysaccharidosis IIIA","volume":"12","author":"Parker","year":"2020","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109224_bb0035","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"Simonaro","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109224_bb0040","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","article-title":"Reactive astrocytes: production, function, and therapeutic potential","volume":"46","author":"Liddelow","year":"2017","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109224_bb0045","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020628","article-title":"Astrocytes in neurodegenerative disease","volume":"7","author":"Phatnani","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"7638","key":"10.1016\/j.ymgme.2025.109224_bb0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109224_bb0055","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41593-020-00783-4","article-title":"Reactive astrocyte nomenclature, definitions, and future directions","volume":"24","author":"Escartin","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"7883","key":"10.1016\/j.ymgme.2025.109224_bb0060","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-021-03960-y","article-title":"Neurotoxic reactive astrocytes induce cell death via saturated lipids","volume":"599","author":"Guttenplan","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109224_bb0065","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1038\/s41467-020-17514-9","article-title":"Knockout of reactive astrocyte activating factors slows disease progression in an ALS mouse model","volume":"11","author":"Guttenplan","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109224_bb0070","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","article-title":"Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease","volume":"24","author":"Yun","year":"2018","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109224_bb0075","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/glycob\/9.12.1389","article-title":"A mouse model for mucopolysaccharidosis type III a (Sanfilippo syndrome)","volume":"9","author":"Bhaumik","year":"1999","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2025.109224_bb0080","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.omtm.2019.10.009","article-title":"Enhancing the therapeutic potential of sulfamidase for the treatment of mucopolysaccharidosis IIIA","volume":"15","author":"Sorrentino","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109224_bb0085","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.ymthe.2020.02.005","article-title":"The amyloid inhibitor CLR01 relieves autophagy and ameliorates neuropathology in a severe lysosomal storage disease","volume":"28","author":"Monaco","year":"2020","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109224_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ymgme.2015.03.002","article-title":"Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA mice","volume":"115","author":"Beard","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"18","key":"10.1016\/j.ymgme.2025.109224_bb0095","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","article-title":"Genomic analysis of reactive astrogliosis","volume":"32","author":"Zamanian","year":"2012","journal-title":"J. Neurosci."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109224_bb0100","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1172\/JCI66778","article-title":"Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy","volume":"123","author":"Haurigot","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109224_bb0105","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymgme.2025.109224_bb0110","article-title":"Possible role of the transglutaminases in the pathogenesis of Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"2011","author":"Martin","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109224_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00726-014-1864-2","article-title":"Transglutaminase 2 and neuroinflammation","volume":"47","author":"Ientile","year":"2015","journal-title":"Amino Acids"},{"issue":"6","key":"10.1016\/j.ymgme.2025.109224_bb0120","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/cyto.a.23652","article-title":"Concurrent detection of lysosome and tissue transglutaminase activation in relation to cell cycle position during apoptosis induced by different anticancer drugs","volume":"95","author":"Halicka","year":"2019","journal-title":"Cytometry A"},{"issue":"22","key":"10.1016\/j.ymgme.2025.109224_bb0125","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1016\/j.cell.2022.09.033","article-title":"TREM2 drives microglia response to amyloid-beta via SYK-dependent and -independent pathways","volume":"185","author":"Wang","year":"2022","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.ymgme.2025.109224_bb0130","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.1074\/jbc.270.17.9748","article-title":"Isolation and characterization of the human tissue transglutaminase gene promoter","volume":"270","author":"Lu","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ymgme.2025.109224_bb0135","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.4161\/auto.5.8.10040","article-title":"Transglutaminase 2 is involved in autophagosome maturation","volume":"5","author":"D\u2019Eletto","year":"2009","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109224_bb0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/1567205020666230804100831","article-title":"Amyloid-beta-induced transglutaminase 2 expression and activities are modulated by 2-Pentadecyl-2-Oxazoline in mouse and human microglial cell lines","volume":"20","author":"Parente","year":"2023","journal-title":"Curr. Alzheimer Res."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109224_bb0145","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1523\/JNEUROSCI.3263-04.2005","article-title":"Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice","volume":"25","author":"Halverson","year":"2005","journal-title":"J. Neurosci."},{"issue":"1\u20133","key":"10.1016\/j.ymgme.2025.109224_bb0150","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1007999114779","article-title":"In vitro neurotoxicity of amyloid beta-peptide cross-linked by transglutaminase","volume":"23","author":"Shinagawa","year":"1997","journal-title":"Cytotechnology"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109224_bb0155","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1750-3639.2008.00197.x","article-title":"Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer\u2019s disease brain","volume":"19","author":"Wilhelmus","year":"2009","journal-title":"Brain Pathol."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109224_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101432","article-title":"Cathepsin B inhibition blocks amyloidogenesis in the mouse models of neurological lysosomal diseases MPS IIIC and sialidosis","volume":"33","author":"Viana","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109224_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108271","article-title":"GLP-1 receptor agonist NLY01 reduces retinal inflammation and neuron death secondary to ocular hypertension","volume":"33","author":"Sterling","year":"2020","journal-title":"Cell Rep."},{"issue":"24","key":"10.1016\/j.ymgme.2025.109224_bb0170","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1021\/acs.biochem.8b00204","article-title":"Cystamine and disulfiram inhibit human transglutaminase 2 via an oxidative mechanism","volume":"57","author":"Palanski","year":"2018","journal-title":"Biochemistry"},{"issue":"18","key":"10.1016\/j.ymgme.2025.109224_bb0175","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1038\/sj.onc.1210048","article-title":"Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy","volume":"26","author":"Yuan","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ymgme.2025.109224_bb0180","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/6.4.503","article-title":"Murine mucopolysaccharidosis type I: targeted disruption of the murine alpha-L-iduronidase gene","volume":"6","author":"Clarke","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"25","key":"10.1016\/j.ymgme.2025.109224_bb0185","doi-asserted-by":"crossref","first-page":"14505","DOI":"10.1073\/pnas.96.25.14505","article-title":"Mouse model of Sanfilippo syndrome type B produced by targeted disruption of the gene encoding alpha-N-acetylglucosaminidase","volume":"96","author":"Li","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922500215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671922500215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:41:46Z","timestamp":1778798506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671922500215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S109671922500215X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109224","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progressive activation of the astrocyte A1 phenotype underlies microglia-astroglia crosstalk and contributes to neuroinflammation in neuronopathic MPS","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109224"}}